[Preliminary evaluation of the effectiveness of specific anti-HBs immunoglobulin for prevention of hepatitis B in infants born to mothers who are carriers of HBsAg].
D002353:Carrier State / Q000276:immunology; D002986:Clinical Trials as Topic; D005260:Female; D006509:Hepatitis B / Q000276:immunology / Q000517:prevention & control*; D006510:Hepatitis B Antibodies / Q000276:immunology*; D006514:Hepatitis B Surface Antigens / Q000276:immunology*; D006801:Humans; D007116:Immunization, Passive; D007231:Infant, Newborn; D011247:Pregnancy; D011251:Pregnancy Complications, Infectious / Q000276:immunology
D006510:Hepatitis B Antibodies; D006514:Hepatitis B Surface Antigens
Wstepna ocena skuteczności swoistej immunoglobuliny anty-HBs w profilaktyce zakazeń wirusem hepatitis B u dzieci urodzonych z matek nosicielek HBsAg.